Arcus Biosciences, Inc.

RCUSNYSEHealthcareBiotechnology

$22.12- (-)1Y +38.55%

As of Oct 16, 2026 close

Market cap: $2.88B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $15.38$31.74
Volume (live): -
Avg. volume (3M): 1.58M

Arcus Biosciences, Inc. (RCUS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Arcus Biosciences, Inc. stock.

Analyst Consensus Rating

Investment consensus from 11 professional research analysts

Consensus Rating

Buy

Based on 11 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$38.60

+74.50% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest RCUS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 5, 2026	Jason Zemansky	BofA Securities	Maintains	Hold	$29.00
Oct 3, 2026	Charles Zhu	LifeSci Capital	Maintains	Buy	$46.00
Sep 30, 2026	Robert Driscoll	Wedbush	Maintains	Buy	$43.00
Sep 25, 2026	Emily Bodnar	HC Wainwright	Maintains	Buy	$45.00
Sep 16, 2026	Tara Bancroft	TD Cowen	Initiates	Buy	-
Sep 10, 2026	Yigal Nochomovitz	Citi	Maintains	Buy	$45.00
Sep 9, 2026	Yigal Nochomovitz	Citi	Maintains	Buy	$45.00
Sep 8, 2026	Supawat Thongthip	Truist	Reiterates	Buy	$35.00 → $40.00 +5.00 (+14.3%)
Aug 10, 2026	Richard Law CFA	Goldman Sachs	Initiates Coverage	Buy	$34.00 → $42.00 +8.00 (+23.5%)
Aug 10, 2026	Terence Flynn	Morgan Stanley	Reiterates	Hold	$22.00 → $23.00 +1.00 (+4.5%)
Aug 6, 2026	Eva Fortea Verdejo	Wells Fargo	Initiates Coverage	Hold	$23.00 → $26.00 +3.00 (+13.0%)
Aug 5, 2026	Salim Syed	Mizuho	Maintains	Buy	$47.00

Jason Zemansky

BofA Securities

HoldMaintains

$29.00

Oct 5

Charles Zhu

LifeSci Capital

BuyMaintains

$46.00

Oct 3

Robert Driscoll

Wedbush

BuyMaintains

$43.00

Sep 30

Emily Bodnar

HC Wainwright

BuyMaintains

$45.00

Sep 25

Tara Bancroft

TD Cowen

BuyInitiates

Sep 16

Yigal Nochomovitz

Citi

BuyMaintains

$45.00

Sep 10

Yigal Nochomovitz

Citi

BuyMaintains

$45.00

Sep 9

Supawat Thongthip

Truist

BuyReiterates

$35.00 → $40.00

Sep 8

Richard Law CFA

Goldman Sachs

BuyInitiates Coverage

$34.00 → $42.00

Aug 10

Terence Flynn

Morgan Stanley

HoldReiterates

$22.00 → $23.00

Aug 10

Eva Fortea Verdejo

Wells Fargo

HoldInitiates Coverage

$23.00 → $26.00

Aug 6

Salim Syed

Mizuho

BuyMaintains

$47.00

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 5, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for RCUS?

The analyst consensus rating for RCUS is Buy, based on the latest ratings from 11 analysts over the last 90 days.

What is the average price target for RCUS?

The average 12-month price target for RCUS is $38.60, representing an upside of 74.5% from the Oct 16, 2026 close of $22.12.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.